• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,383.53 751.88
( 0.98%)
Global Indices
Nasdaq
48,208.69 277.76
(0.58%)
Dow Jones
6,845.97 42.16
(0.62%)
Hang Seng
56,916.27 1,020.95
(1.83%)
Nikkei 225
10,579.52 -29.36
(-0.28%)
Forex
USD-INR
92.44 -0.46
(-0.50%)
EUR-INR
107.96 0.52
(0.48%)
GBP-INR
124.05 0.88
(0.72%)
JPY-INR
0.58 0.00
(0.32%)

EQUITY - MARKET SCREENER

Concord Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543960
INE338H01029
174.4719509
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CONCORDBIO
34.72
11027.59
EPS(TTM)
Face Value()
Div & Yield %
30.36
1
0.83
 
( Cr)
ParticularsDec 2025 ( Cr)Sep 2025 ( Cr)Jun 2025 ( Cr)
Gross Sales278.13247.06203.99
Other Operating Income0.000.000.00
Other Income 10.0813.4313.68
Total Income288.22260.49217.67
Total Expenditure 179.19156.52142.59
PBIDT109.03103.9775.07
Interest 0.060.060.06
PBDT108.97103.9175.02
Depreciation18.6718.3917.78
Tax21.5722.0014.08
Fringe Benefit Tax0.000.000.00
Deferred Tax0.950.630.60
Reported Profit After Tax67.7862.9042.57
Extra-ordinary Items -2.460.000.00
Adjusted Profit After Extra-ordinary item70.2462.9042.57
EPS (Unit Curr.)6.486.014.07
EPS (Adj) (Unit Curr.)6.486.014.07
Calculated EPS (Unit Curr.)6.486.014.07
Calculated EPS (Adj) (Unit Curr.)6.486.014.07
Calculated EPS (Ann.) (Unit Curr.)25.9224.0516.27
Calculated EPS (Adj) (Ann.) (Unit Curr.)25.9224.0516.27
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity10.4610.4610.46
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)39.2042.0836.80
PBDTM(%)39.1842.0636.78
PATM(%)24.3725.4620.87